已收录 268921 条政策
 政策提纲
  • 暂无提纲
Minimally invasive valve surgery in high-risk patients
[摘要] Since its inception in 1996, the performance of minimally invasive valve surgery (MIVS) has grown significantly (1-3). Many different approaches for MIVS have been described, however, the most commonly utilized include a right anterior or lateral thoracotomy, an upper hemisternotomy, and the use of robotic technology ( Figure 1 ) (4). When compared with a standard median sternotomy (ST), the reported benefits of MIVS include: reduced surgical trauma, post-operative pain, blood loss and need for re-operation for bleeding, shorter ventilation time, intensive care unit (ICU) and hospital length of stay (LOS), decreased incidence of post-operative atrial fibrillation, reduced cost, less use of rehabilitation resources, improved cosmesis, and a more rapid return to functional activity (2,5-7). Because of these advantages, high-risk patients may especially benefit from this approach, as opposed to ST (8,9). However, these potential benefits may come with an increased risk of stroke, aortic dissection or aortic injury, phrenic nerve palsy, groin infections/complications, and increased cross-clamp, cardiopulmonary bypass, and procedure time (5).
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 呼吸医学
[关键词]  [时效性] 
   浏览次数:14      统一登录查看全文      激活码登录查看全文